{"id":"dymista","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL639","moleculeType":"Small molecule","molecularWeight":"381.91"},"aliases":["Azelastine hydrochloride and Fluticasone propionate (generic name)","AZE/FLU"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"4c557ec4-c4cf-11df-851a-0800200c9a66","title":"DYMISTA (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE) SPRAY, METERED [VIATRIS SPECIALTY LLC]"},"ecosystem":[],"_scrapedAt":"2026-03-28T01:10:23.668Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02402465","phase":"PHASE4","title":"Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02","conditions":"Allergic Rhinitis","enrollment":22},{"nctId":"NCT05146206","phase":"","title":"Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray","status":"COMPLETED","sponsor":"Community and Patient Preference Research Pty Ltd","startDate":"2021-11-08","conditions":"Allergic Rhinitis","enrollment":426},{"nctId":"NCT05684380","phase":"PHASE3","title":"Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)","status":"UNKNOWN","sponsor":"EMS","startDate":"2024-09","conditions":"Allergic Rhinitis","enrollment":514},{"nctId":"NCT06180083","phase":"PHASE1","title":"Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2023-03-24","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":56},{"nctId":"NCT05158972","phase":"","title":"Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2021-10-27","conditions":"Allergic Rhinitis","enrollment":924},{"nctId":"NCT04601324","phase":"PHASE4","title":"Allergic Rhinitis Combination Pharmacotherapy Efficacy Study","status":"WITHDRAWN","sponsor":"St. Paul's Sinus Centre","startDate":"2020-12-15","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT06051786","phase":"PHASE2","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Synmosa Biopharma Corp.","startDate":"2020-08-20","conditions":"Allergic Rhinitis","enrollment":136},{"nctId":"NCT04652245","phase":"PHASE4","title":"Dymista Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2020-12-14","conditions":"Seasonal Allergic Rhinitis","enrollment":216},{"nctId":"NCT03599791","phase":"PHASE3","title":"DYmista NAsal Spray in CHInese Patients","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2018-06-29","conditions":"Allergic Rhinitis","enrollment":900},{"nctId":"NCT03004131","phase":"PHASE4","title":"MP-AzeFlu Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2017-01-07","conditions":"Seasonal Allergic Rhinitis","enrollment":82},{"nctId":"NCT01190852","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT01194622","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT02883439","phase":"NA","title":"Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate","status":"WITHDRAWN","sponsor":"University Hospital, Ghent","startDate":"2016-08","conditions":"Bioavailability Study","enrollment":""},{"nctId":"NCT02953106","phase":"PHASE4","title":"Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis","status":"TERMINATED","sponsor":"University of Dundee","startDate":"2017-01-20","conditions":"Asthma, Allergic, Rhinitis,Allergic, Allergy","enrollment":7},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT02238353","phase":"PHASE4","title":"AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)","status":"UNKNOWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-10","conditions":"Allergic Rhinitis, House Dust Mite Allergy","enrollment":45},{"nctId":"NCT01915823","phase":"PHASE3","title":"Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2013-07","conditions":"Seasonal Allergic Rhinitis","enrollment":348},{"nctId":"NCT01794741","phase":"PHASE3","title":"3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2013-02","conditions":"Allergic Rhinitis","enrollment":405},{"nctId":"NCT02279563","phase":"PHASE2","title":"A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Apotex Inc.","startDate":"2013-12","conditions":"Seasonal Allergic Rhinitis","enrollment":595},{"nctId":"NCT02249663","phase":"PHASE3","title":"Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™","status":"UNKNOWN","sponsor":"Teva Pharmaceuticals USA","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1535},{"nctId":"NCT00845598","phase":"PHASE4","title":"Azelastine Fluticasone Combination vs. Fluticasone","status":"WITHDRAWN","sponsor":"University of Dundee","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Dymista","genericName":"Dymista","companyName":"Mylan Inc.","companyId":"mylan-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}